Skip to content

Research on the prevalence of OBI and viral molecular characteristics in patients with pulmonary tuberculosis

Research on the prevalence of OBI and viral molecular characteristics in patients with pulmonary tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116348
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-12
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Observation group:None

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with tuberculosis were selected as research subjects (age >=18 years, clinically diagnosed with active tuberculosis), and the diagnostic criteria were based on the "Diagnostic Criteria for Tuberculosis (WS 288—2017)". For OBI samples: chemiluminescence was used to detect hepatitis B serological markers (HBsAg), and fluorescent quantitative PCR was used to detect serum HBV-DNA. Samples with HBV-DNA >20 IU/mL and HBsAg negative were included.

Exclusion criteria

Exclusion criteria: Excluding those with co-infection of HIV/HCV, cirrhosis, liver cancer, or other severe liver diseases; excluding malignant tumors and severe wasting diseases; excluding those who have recently received immunosuppressive therapy before being included in the study.

Design outcomes

Primary

MeasureTime frame
count;

Countries

China

Contacts

Public ContactFuchu Qian

Huzhou Center Hospital

qfc313009@126.com+86 572 2555801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026